Neuropathology and Applied Neurobiology 43, 315-329 Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type Aims: The aim of this study was to identify early foci of a-synuclein (a-syn pathology) accumulation, subsequent progression and neurodegeneration in multiple system atrophy of the cerebellar type (MSA-C). Methods: We analysed 70-lm-thick sections of 10 cases with MSA-C and 24 normal controls. Results: MSA-C cases with the lowest burden of pathology showed a-syn glial cytoplasmic inclusions (GCIs) in the cerebellum as well as in medullary and pontine cerebellar projections. Cerebellar pathology was highly selective and severely involved subcortical white matter, whereas deep white matter and granular layer were only mildly affected and the molecular layer was spared. Loss of Purkinje cells increased with disease duration and was associated with neuronal and axonal abnormalities. Neocortex, basal ganglia and spinal cord became consecutively involved with the increasing burden of a-syn pathology, followed by hippocampus, amygdala, and, finally, the visual cortex. GCIs were associated with myelinated axons, and the severity of GCIs correlated with demyelination. Conclusions: Our findings indicate that cerebellar subcortical white matter and cerebellar brainstem projections are likely the earliest foci of a-syn pathology in MSA-C, followed by involvement of more widespread regions of the central nervous system and neurodegeneration with disease progression.
Introduction
Multiple system atrophy (MSA) is a relentlessly progressive adult-onset neurodegenerative disease of unknown aetiology for which no disease-modifying therapy exists [1] . Two major clinico-pathological subtypes can de delineated: MSA-C [olivo-ponto-cerebellar atrophy (OPCA)], mainly characterized by cerebellar ataxia, and MSA-P (striato-nigral degeneration), presenting as a parkinsonian syndrome that is poorly responsive to dopaminergic therapy [2] [3] [4] . To a variable extent, the clinical features of both subtypes also include autonomic failure, which can predate motor symptoms, as well as pyramidal signs [5] [6] [7] . While MSA is generally believed to be a sporadic disease, emerging evidence indicates that rare genetic variants increase susceptibility to the disease [8] [9] [10] . Indeed, some of these mutations cause significant oligodendroglial asynuclein (a-syn) deposition and cause morphological phenotypes that resemble MSA, as exemplified by the G51D SNCA mutation which shows a remarkable convergence of neuronal and oligodendroglial a-syn inclusions [11] .
The neuropathological hallmarks of MSA are a-synpositive oligodendroglial cytoplasmic inclusions (GCIs) and, to a lesser extent, infrequent a-syn-positive neuronal inclusions (NIs) in the central nervous system (CNS) [2, 7, [11] [12] [13] . a-Syn is a 17-kDa protein encoded by the SNCA gene at location 4q22.1 that is predominantly expressed in neurons, where it localizes to synaptic terminals and plays a role in vesicle transport and turnover [14, 15] . When misfolding occurs, the amyloidogenic region of a-syn forms b-sheets, leading to protofibrils and the formation of fibrils that accumulate into intra-cytoplasmic amyloid aggregates as GCIs and rarely as NIs in MSA. Similar a-syn aggregates also characterize the pathology of Parkinson's disease (PD) and dementia with Lewy bodies (DLB), albeit in a predominantly neuronal localization to form Lewy bodies with no GCIs [16, 17] . Nonetheless, both Lewy bodies and GCIs show a similar epitope profile of a-syn, thereby suggesting that similar a-syn protein domains aggregate to form these inclusions which show properties of amyloid deposits [11, 18] .
Progressive spreading disease protein aggregates in many of non-prion neurodegenerative disorders is increasingly recognized as a unifying pathological principle of these clinically diverse disorders, including synucleinopathies [19] [20] [21] . Furthermore, converging lines of evidence from cell culture and animal model experiments as well as from human tissue studies support the idea of cell-to-cell a-syn transmission in PD and DLB [22] [23] [24] [25] [26] [27] [28] . However, given the mainly oligodendroglial localization of a-syn aggregates in MSA, it is currently debated whether this concept of protein propagation can be extended to MSA. While there seems to be little or no oligodendroglial expression of a-syn under normal conditions [29] , this could be changed in a pathological setting like MSA [18] . Moreover, it remains enigmatic where and how a-syn aggregation begins in MSA, what possibly characterizes the earliest dissemination of a-syn pathology, and what potentially determines oligodendroglial and neuronal vulnerability to a-syn pathology.
In this study, we aimed to identify early foci of a-syn pathology in a cohort of clinically well-defined cases with MSA-C by implementing a methodological approach pioneered by Braak and colleagues that uses 70-lm-thick sections to enable a highly sensitive analysis of protein aggregation pathology and its anatomical localization in neurodegenerative diseases [30] .
Methods

Autopsy cohort
Of 47 patients with a clinical and confirmed neuropathological diagnosis of MSA [2, 7, 31, 32] who were followed longitudinally to autopsy in the Center for Neurodegenerative Disease Research (CNDR) at the University of Pennsylvania between 1989 and 2013, we included all cases with a clinical picture of MSA-C and a neuropathological picture of OPCA (n = 10, 1 female, 9 males; mean age at onset AE SD: 58 AE 7.7 years, range 51-74 years, mean disease duration AE SD: 6.1 AE 3.3 years, range 3.5-14 years) as well as 24 controls age-matched to the MSA-C group that did not show clinical or neuropathological signs of neurodegenerative disease (7 female, 17 male, mean age at death 63.9 AE 6.0 years). Informed consent for autopsy was obtained for all patients or from their next of kin. The study was approved by the University of Pennsylvania Institutional Review Board. Detailed clinical characteristics (gender, age at onset, age at death, clinical symptoms of onset, disease duration) were ascertained from an integrated autopsy database, as described previously [33, 34] and by retrospective chart review of clinical visits within the University of Pennsylvania Health System (Table 1) .
Tissue preparation, staining and immunohistochemistry
Pathology was examined in 20 regions of the CNS: the middle frontal gyrus, gyrus rectus and orbital gyri, the agranular motor cortex (Brodmann areas 4 and 6), somatosensory cortex, superior or middle temporal gyrus, angular gyrus, precuneus (Brodmann area 7), visual cortex (Brodmann areas 17 and 18), anterior cingulate gyrus, hypothalamus, amygdala, hippocampal formation, striatum and pallidum (the striatum block included anterior portions of the caudate nucleus and putamen plus the accumbens nucleus, where the caudate nucleus and putamen merge), the thalamus, midbrain [including the substantia nigra (SN) and red nucleus (RN)], upper pons at the level of the locus coeruleus, lower pons (including the motor nucleus of cranial nerve VII), the medulla oblongata at the level of the hypoglossal nucleus (XII) and inferior olive (IO), the cerebellum (including both a portion of the cerebellar cortex and dentate nucleus), and the cervical spinal cord. After overnight fixation of thin 0.5-1-cm-thick tissue blocks to ensure uniform penetration of 10% neutral buffered formalin, all tissue samples were embedded in paraffin using standardized cassettes, sectioned at 6-7 lm, and stained with haematoxylin and eosin (HE) and for immunohistochemistry (IHC) as previously described [17, 35] . Briefly, IHC was performed with antibodies to a-syn (monoclonal antibody (mab) Syn303; 1:4000, generated in CNDR) [36] , hyperphosphorylated tau (mab PHF1; 1:1000, gift from Dr. Peter Davies), pTDP-43 (rat antibody p409/410, 1:1000, gift from Dr. Manuela Neumann) [37] and amyloid-b (mab NAB228; 1:15 000; generated in CNDR) [38] , whereas histochemical staining with HE as well as thioflavin S were performed as reviewed recently [39] . Neurofibrillary tangle stages and CERAD neuritic plaque scores are shown in Table 1 . Table 1 . Demographic data of cases with multiple system atrophy of the cerebellar type (MSA-C) and severity of a-syn pathology in different regions of the central nervous system as rated on a semi-quantitative rating scale To study each of the CNS regions in greater neuroanatomical detail, additional sets of 70 lm sections were prepared as described previously [17, 30] from the same paraffin blocks as those used above. This thick section technique is performed on free-floating sections and permits recognition of specific cell types and cytoarchitectonic units owing to the visualization of large numbers of biological structures in a more threedimensional manner than is possible with conventional 6-lm-thick sections [17, 30] . The sections were stained for analysis of a-syn pathology and to provide for a more topographical overview and to assess neuronal loss (NL), we combined a-syn IHC with a pigment-Nissl stain (PN) for lipofuscin pigment (aldehyde fuchsin) and basophilic Nissl material (Darrow red) as described [30] . In addition, Campbell-Switzer silver staining (CS) was performed as previously described [40] . Severity of a-syn pathology and NL were assessed according to a 4-point semiquantitative rating scale (0, absent or not detectable; 1, ≤2 aggregates per region + mild; 2, moderate ++; 3, severe/numerous +++) [28, 41] and was adjusted for NL. Double-labelling IHC was performed on selected 70 lm sections using the a-syn antibody described above together with the Vector Labs, Burlingame, CA, USA, SG (SK-4700; Vector) blue chromogen and the SMI-311 mab (1:1000; Covance, Princeton, NJ, USA), the rabbit polyclonal antibody (pab) for oligodendrocyte-specific protein (1:400; Abcam, Cambridge, UK) and the anti-oligo2 antibody (1:400; Millipore, Billerica, MA, USA).
For double-labelling immunofluorescence (IF), 15 lm frozen sections were microwaved in 10 mM citrate buffer, pH 6.0, for 15 min; blocked in 2% FBS with 0.1 M Tris and incubated with the mouse mab syn-506 (specific for a-synuclein, amino acids 1-89; 1:10 000; CNDR [42] ) and rabbit pab Olig2 (specific for oligodendrocytes; 1:250; Millipore), rat mab TA51 (specific for phosphorylated heavy and medium molecular weight neurofilament; 1:10; CNDR [43] ), rabbit pab NFL1/2 (specific for low molecular weight neurofilament; Age, age in years; AMY, amygdala; ANG, angular gyrus; ANG WM, angular gyrus white matter; CB DEN, cerebellum, dentate nucleus; CB DWM, cerebellum, deep white matter; CB GL, cerebellum, granular layer; CB MOL, cerebellum, molecular layer; CB PCL, cerebellum, Purkinje cell layer; CB SWM, cerebellum, subcortical white matter; CE, CERAD score; CG, anterior cingulate gyrus; CG WM, anterior cingulate gyrus white matter; CI, internal capsule; CSC CST, cervical spinal cord, corticospinal tract; CST EPT, CSC, extrapyramidal tracts (rubro-, reticulo-, olivospinal tracts); CSC SCT, CSC, spinocerebellar tract; CSC ST, CSC, spinobulbar tracts; CSC STT, CSC, spinothalamic tract; Dur, duration of disease (months); ENT, entorhinal cortex; ENT WM, entorhinal cortex white matter, HIP CA1,2, hippocampus, cornuammonis regions 1 and 2; HIP CA3,4, hippocampus, Ammon's horn regions 3 and 4; HIP DEN, dentate gyrus of hippocampus; HIP SR, hippocampus stratum radiatum, LAM I-XIII -laminae 1 to 8 of spinal cord gray matter; LAM IX, lamina 9 of spinal cord gray matter; MBCC, crus cerebri; MB ML, midbrain, medial lemniscus; MB RN, midbrain, red nucleus; MB SN, midbrain substantia nigra; MED IO, medulla, inferior olive; MED ARC, medulla, arcuate nucleus; MED CST, medulla, corticospinal tract; MED ICP, medulla, inferior cerebellar peduncle; MED ML, medulla, medial lemniscus; MED OCF, medulla, olivo-cerebellar fibres; MED X, medulla, dorsal motor nucleus of the vagal nerve; MED XII, medulla, hypoglossal nucleus; MF, middle frontal gyrus; MF WM, middle frontal gyrus white matter, MOT, motor cortex (Brodmann areas 4 and 6); MOT WM, motor cortex white matter, NFT, Braak stage of neurofibrillary tangles; OF, orbital gyrus and gyrus rectus; OF WM, orbital gyrus and gyrus rectus white matter; PAL, pallidum; PON CST, pons, corticospinal tract; PON LC, pons, locus coeruleus; PON MCP, pons, middle cerebellar peduncle; PON SCP, pons, superior cerebellar peduncle; PON TF, pontocerebellar fibres; PUT, putamen; SEN, somatosensory cortex; SEN WM, somatosensory cortex white matter; SMT, superior and middle temporal gyrus, THA, thalamus, VIS, visual cortex (Brodmann areas 17 and 18); VIS WM, visual cortex white matter. Colours indicate severity of pathology from green colour = no pathology to red colour = severe pathology. in 2%FBS in 0.1 M Tris. Slides were cover-slipped using Vectashield mounting media with DAPI (Vector) and digitalized images were obtained using a Leica TCS SPE-II scanning laser confocal microscope.
Targeted next-generation sequencing
Genomic DNA was extracted from frozen brain tissue using commercial reagents (DNA mini kit; Qiagen, Valencia, CA, US). To exclude mutations in COQ2 which have been associated with MSA, targeted sequencing was performed using a neurodegenerative disease-focused panel that targets the coding exons of 45 genes, including COQ2. The library of the target regions was prepared with Haloplex enrichment kit (Agilent Technologies, Santa Clara, CA, USA) according to the manufacturer's protocol. Sequencing was performed on an Illumina, San Diego, CA, USA, Mi-Seq using 150 base paired-end reads. Following quality control procedures, alignment of sequence reads and variant calling was assessed using SureCall software (Agilent).
Statistical analysis
Data analysis was performed using SPSS (version 17.0; SPSS Inc., Chicago, IL, USA). The average (and range) of data on patient characteristics were estimated by calculating the median (and 25th-75th percentiles). Differences between two clinical subgroups were compared using Wilcoxon Mann-Whitney test. To compare raw data of multiple subgroups, Kruskal-Wallis analysis of variance on ranks was applied and in case of significance, by Dunn's method. Trend analysis was conducted using the Mantel-Haenszel chi-square test. All correlations were studied using Spearman's rank order correlation coefficient. Bonferroni-correction for multiple testing was applied when contrasts were not driven by a specific hypothesis. For all other tests, P-values < 0.05 were considered significant. All statistical tests were two-sided.
Results
Morphology of a-syn pathology in MSA
Main types of a-syn inclusions in MSA-C We first analysed the morphology of a-syn pathology in MSA-C in 70-lm-thick sections which allows for a more three-dimensional view of the histology than conventional 6-lm-thick sections wherein objects have a more two-dimensional appearance [17, 30] . We observed three main types of a-syn inclusions in MSA-C and none of these pathologies were observed in any of the age-matched controls: The most abundant pathology consisted of GCIs in white and (to a lesser extent) grey matter of the CNS. GCIs and neuritic a-syn inclusions (NRI) in axons constituted the earliest changes in regions with a low overall burden of a-syn pathology ( Figure 1A ). GCIs frequently were associated with considerable swelling of the oligodendroglial nucleus and cytoplasm. NIs were rare and not as widespread as GCIs but appeared to gradually develop with the increasing burden of a-syn pathology.
Sequence of neuronal a-syn aggregates in MSA-C Initially, and prior to the development of NI, neurons showed abnormalities which included cytoplasmic and nuclear swelling, cytoplasmic loosening of lipofuscin pigment or changes in dendritic architecture ( Figure 1B, H) . With disease progression, these changes were accompanied by the development of nuclear a-syn skeins, and, then, by the formation of granular cytoplasmic aggregates ( Figure 1C -E and I-L). With increasing accumulation of cytoplasmic a-syn aggregates, neurons became increasingly surrounded by dendritic NRI ( Figure 1F ). In addition, accumulation of a-syn inclusions was accompanied by progressive NL, which was accompanied by the extracellular retention of a-syn aggregates and extracellular lipofuscin pigment remnants in the neuropil ( Figure 1G ). Remarkably, NL was frequently observed in groups of neurons that did not (or only to a very mild extent) show NI or NRI. As an example, severe loss of cerebellar Purkinje cells (PC) was detected in cases with a short disease duration, and these cells did not show any NI or NRI. Similarly, neurons of the SN and the locus coeruleus showed severe NL but only mild NI.
Four phases of a-syn pathology in MSA-C On the basis of the different types of a-syn inclusions described above, we proceeded to analyse phases of a-syn pathology in MSA-C according to an increasing overall burden of pathology (Table 1) .
Phase 1: cerebellum, and cerebellar brainstem connectivities Generally, MSA-C cases with the lowest overall burden of pathology showed involvement of cerebellar subcortical white matter, olivo-cerebellar fibres in the medulla, the inferior cerebellar peduncle of the medulla, pontocerebellar fibres and the middle and (to a lesser extent) the superior cerebellar peduncles (Table 1) .
We observed a highly selective pattern of cerebellar involvement, which persisted with an increasing burden of a-syn pathology (Figure 2 ). Cerebellar pathology was prominent in the corpus cerebelli, whereas the nodulus (vestibulo-cerebellum) was hardly affected. In addition, pathology more severely affected the vermis cerebelli than the hemispheres. GCIs severely involved the cerebellar subcortical white matter, whereas deep white matter and the granular layer were only mildly involved (Figure 2A-C) . Double-labelling IF demonstrated that a-syn inclusions in the granular layer were GCIs and not NIs ( Figure S1F ). The dentate nucleus developed NIs only in cases with a high burden of GCI pathology, whereas the molecular layer was entirely spared of NIs (Table 1 , Figure 2A -C). Using combined CS + myelin staining and CS + PN staining, we observed GCI in areas with severe pathology to be mostly argyrophilic, whereas GCIs in areas with a lower burden of this a-syn pathology were less positively stained by the CS method ( Figure 2E ). Importantly, we found a close spatial relationship between GCIs and myelinated axons, which suggests that these GCIs were in myelinating oligodendroglial cells (Figure 2F-H ). In addition, we observed argyrophilic aggregates in oligodendroglial processes that ensheathed myelinated axons ( Figure 2H ), which further suggests that these GCIs are in myelinating oligodendroglia rather than in satellite cells. Moreover, the regional severity of GCI pathology correlated with the severity of myelin pallor, with the most severe myelin loss observed in subcortical white matter, whereas myelin in the deep white matter was much better preserved ( Figure 2D ). In addition, cerebellar involvement was characterized by loss of PCs that increased with disease duration ( Figure 2I, J) . Remarkably, the PCs themselves did not show any a-syn inclusions but showed other evidence of neuronal abnormalities, including distortion of dendrites as well as axonal swellings mainly in the proximal parts of PC axons ( Figure 2K, L) . In contrast to PCs, NL of dentate nucleus neurons was only observed in cases with a later phase of a-syn pathology and long disease duration. Similar to our observations on the cerebellum, the earliest pathology in the brainstem prominently involved white matter tracts (Figure 3 ). In the medulla oblongata, a-syn pathology was observed to a lesser extent in the IO ( Figure 3A, B) than elsewhere in the medulla ( Figure 3C ), and abundant GCIs were seen in olivo-cerebellar fibres. In addition, a-syn-positive GCIs were observed in the inferior cerebellar peduncle. While no NIs were detectable in the IO, IO neurons were often surrounded by a dust-like cloud of a-syn inclusions, presumably in dendrites, and there was mild loss of IO neurons ( Figure 3A, B) . In the pons, GCIs and NRIs were observed in pontocerebellar fibres (Table 1 , Figure 3D , E), especially in lower pontine areas. In addition, we observed a-syn-positive GCIs in the middle and superior cerebellar peduncles. In contrast to cerebellum and brainstem, the basal ganglia, substantia nigra, neocortical fields, limbic system centres, and the spinal cord were uninvolved in phase 1 cases. None of the control cases showed any a-syn pathology.
Phase 2: pyramidal and extrapyramidal white matter With an increasing overall burden of a-syn-positive GCI pathology, in addition to the findings described above, a-syn inclusions became detectable in cerebellar deep Table 1 ), GCIs were seen in the hypoglossal nucleus. Scale bar in A, C and D indicates 500 lm, scale bars in B and in E-N indicate 100 lm.
white matter, whereas the dentate nucleus still remained free of NI (Table 1) . Moreover, there was increasing loss of PC in the cerebellar cortex ( Figure 2I, J) . In the medulla, GCIs became detectable in the medial lemniscus and also in fibres of the corticospinal tract within the medullary pyramids. The pontine pyramidal bundles also displayed a-syn-positive GCIs, though to a lesser extent than the pontocerebellar fibres (Figure 2D) . In the midbrain, GCIs and NRIs prominently involved fibres within the crura cerebri (Table 1 ). In the basal ganglia, cases with the lowest overall burden of a-syn pathology, GCIs and NRIs were present in fibre tracts of the internal capsule (Table 1, Figure 2G ). Double-labelling IHC and IF revealed that these long NRIs in the internal capsule were axonal aggregates of a-syn ( Figure S1C-E) .
GCIs and NRIs were seen to involve different fibre tracts in the spinal cord, including the anterior as well as the lateral portion of the corticospinal tracts, the spino-thalamic, spino-cerebellar and spino-olivary tracts, whereas sensory white matter pathways were not involved until later disease phases (Table 1 ). In addition to white matter fibre tracts, GCIs were also observed in the spinal cord gray matter, whereas NIs were only rarely detected there. Moreover, loss of amotoneurons was rare and limited to cases with the highest overall burden of a-syn-positive GCI pathology ( Table 1) . Sections of the thoracic, lumbar and sacral spinal cord were available for only n = 3 cases, but the spinal cord a-syn GCI pathology there extended all the way down to sacral spinal cord sections and also involved the intermediolateral nucleus.
Phase 3: neocortex and basal ganglia gray matter Cortical a-syn inclusions were first detectable in frontal and temporal cortical areas, whereas the parietal cortex (including the sensory and angular gyrus) was only involved in later phases of MSA-C (Table 1) . Within the cortex, GCIs and NRIs first became detectable in lower cortical layers (layers V, VI), subcortical white matter and deep white matter ( Figure 3H ), whereas NIs and NL were not observed in cases with a low burden of cortical pathology. With an increasing burden of a-syn-positive GCI pathology, NIs also were present, especially in pyramidal cells of lower cortical layers (V, VI), when white matter GCI pathology was very severe.
In the lower medulla, phase 3 cases showed NIs in the IO, although the lesions were infrequent and mild compared to white matter GCIs. With the increasing overall burden of a-syn pathology, NIs in the IO became more common and frequently were surrounded by a dust-like cloud of a-syn inclusions that appeared to be intra-dendritic inclusions (Figure 2A,  B) . Similarly, NL was present in the dorsal motor nucleus of the vagal nerve, whereas NIs were sparse there ( Figure 2C ). In addition, NL as opposed to only infrequent NIs was detected in the locus coeruleus (Table 1) , and in the midbrain, a-syn inclusions were increasingly observed in the RN (Table 1) . Moderate a-syn inclusions (GCIs, NIs) and NL were detectable within the hypothalamus of seven 7 MSA-C cases, which were not among those with the lowest overall burden of pathology. Finally, the thalamus became gradually involved with increasing burden of pathology.
Phase 4: amygdala and hippocampus Cases with further increases in the burden of a-syn inclusions were characterized by involvement of the hippocampus and amygdala (Table 1 ). In the hippocampus, GCIs and NRIs were observed in the external plexiform layer as well as in the stratum radiatum and lacunosum, whereas NIs were rarer and were first detected in the outer sectors of the Ammon's horn (CA1, CA2) as well as in the subiculum. In contrast, the inner sectors of the Ammon's horn (CA3, CA4) and the dentate gyrus were less severely involved and only became involved in the MSA-C cases with the most severe burden of asyn pathology and NL (Table 1, Figure 3I-L) . Occasionally, extensive NRI could be detected within the Ammon's horn ( Figure 3J, K) . Hippocampal involvement was associated with the presence of a-syn pathology in the entorhinal cortex and in the basolateral subnucleus of the amygdala (Table 1) .
In addition to these findings, MSA-C cases with a burden of a-syn inclusions corresponding to phase 4 showed NIs in the cerebellar dentate nucleus (Table 1) and showed a very mild burden of NIs in the dorsal motor nucleus of the vagal nerve and hypoglossal nucleus ( Figure 3L ).
Clinicopathological correlations and genetic results
We next analysed clinicopathological correlations for the entire cohort of MSA-C cases. The patterns of a-syn pathology described above correlated significantly with duration of disease (q = 0.83, P < 0.001) but were not related to age at onset (q = À0.13, P = 0.71) or age at death (q = 0.3, P = 0.38). Furthermore, severity of a-syn pathology increased significantly with duration of disease across many of the regions analysed here (Table S1 ). In contrast, we observed no significant correlation between the regional severity of a-syn inclusions and tau or Ab pathology (P > 0.05 and q < 0.04 each). Myelin loss in pons and cerebellum correlated significantly with severity of GCI pathology, and increased with disease duration (q > 0.4, P < 0.05 each).
Although mutations in COQ2 have been associated with an increased risk of MSA, the overwhelming majority of MSA cases present as sporadic disease [45] . We screened the MSA-C cases in this study for genetic variations in COQ2. No pathogenic mutations were identified.
Discussion
The main aim of this study was to determine early foci of a-syn pathology in MSA-C. The major findings can be summarized as follows: (i) cerebellar subcortical white matter and cerebellar brainstem projections represent early foci of a-syn pathology in MSA-C; (ii) cerebellar pathology in MSA-C shows a highly specific pattern of involvement, namely, severe involvement of subcortical white matter, only mild involvement of deep white matter and granular layer, and sparing of the molecular layer. (iii) This pattern appears to be determined by the early involvement of PCs; and; (iv) the pattern of a-syn pathology in MSA-C is indicative of a progressive spread and, therefore, is reminiscent of what has been observed in several other neurodegenerative disorders [19] [20] [21] .
Morphology of a-syn inclusions in thick sections of MSA-C We first analysed the morphology of a-syn aggregates in 70-lm-thick sections. As noted above and reported elsewhere [17, 30, 40] , we emphasize illustrations of 70-lm-thick sections because they allowed us to view the histology and pathology in a more three-dimensional manner than what is possible by examining conventional 6-lm-thick sections. We also examined 6-lm-thick sections for this study, but these provide a shorted depth of viewing that result in objects having a more two-dimensional appearance. In line with previous evidence [2, 7, 12, 13, 39, [46] [47] [48] [49] [50] [51] [52] [53] , we found the main a-syn pathology to consist of white matter GCIs. GCIs were reported to be partially argyrophilic [54] , especially in cases with longer duration of disease ( Figure 2E ). Moreover, similar to Lewy bodies in PD and DLB, GCIs also show properties of amyloids including positivity for thioflavin S and other amyloid binding dyes [18] . Consequently, argyrophilia and positivity for amyloid binding dyes are likely to be a characteristic of more mature a-syn inclusions in MSA-C. NIs and NRIs were less frequent than GCIs, which is also in accordance with previous studies of MSA [55] [56] [57] .
Importantly, our study indicates that neurons in MSA-C manifest other abnormalities that variably include cytoplasmic and nuclear swelling, intraneuronal loosening of lipofuscin pigment ( Figure 1B, H) , and dendritic morphological changes prior to the development of NI ( Figure 2K -L), which we speculate may reflect a form of cellular stress or incipient neurodegeneration. In addition, our study indicates that nuclear asyn aggregates in neurons are more frequent than previously reported [49] . Although a-syn is mainly a presynaptic protein, it was also detected at the inner nuclear membrane [58] . Such nuclear a-syn aggregates could have potentially severe functional consequences in cells that do not show the prominent cytoplasmic aggregates observed in other synucleinopathies [16, 28] .
Cerebellum and its projections as early foci of pathology in MSA-C On the basis of our analysis of a-syn inclusion morphology, we proceeded to look for evidence of a possible spreading of a-syn pathologyin MSA-C. We focused on MSA-C as we expected the spread of a-syn in MSA-P to be different and to require a separate study. Our intention was not to propose a new grading system of MSA-C [7, 12, 46] but, rather, to determine where a-syn pathology might begin and how it progressively spreads in autopsy-confirmed MSA-C cases.
Cases with the lowest overall burden of pathology (phase 1, Table 1 ) showed prominent GCIs in the cerebellar white matter and in medullar and pontine white matter cerebellar projections, which is in agreement with previous neuropathology and neuroimaging studies [2, 7, 12, 32, 46, [59] [60] [61] . GCIs and NRIs were associated with myelin loss in the pontocerebellar fibres ( Figure 2D , E) [62, 63] , which has been linked with the characteristic 'cross-bun sign' detectable in magnetic resonance imaging of living MSA-C patients [64, 65] . Cerebellar involvement was highly selective: Subcortical white matter showed severe GCIs already in cases with a low burden of pathology/short disease duration (Table 1 ). In contrast, deep white matter and the granular layer were affected to a much lesser degree, and the molecular layer remained free of any a-syn inclusions (Table 1, Figure 2A-C) . The dentate nucleus showed NIs only in cases with a long disease duration (Table 1) , which coincides with previous observations [7, 46, 66] . Importantly, GCIs showed a close spatial relation to myelinating axons ( Figure 2F-H) , thereby indicating that GCIs are a-syn lesions that occur in myelinating oligodendroglia (and not in satellite cells). In line with this and previous findings [46, 54] , we found severe myelin loss in regions characterized by early and severe GCI formation, such as cerebellar subcortical white matter or pontocerebellar fibres ( Figure 2D ). We hypothesize that this highly selective pattern of cerebellar involvement in MSA-C could be partially explained by the association of GCI with myelinated fibres. Thus, we found that the cerebellar molecular layer, which contains the unmyelinated parallel fibres of granular layer neurons, remained free of GCI pathology even in cases with the longest disease duration [67] . Similarly, the distal parts of PC axons, which penetrate the cerebellar deep white matter surrounding the dentate nucleus, have been reported to be unmyelinated [68, 69] , which could explain the relative sparing of the cerebellar deep white matter by GCI pathology (Figure 2A) .
With an increasing burden of a-syn pathology (phase 3, Table 1 ), GCIs, Nis, and NRIs became detectable in the neocortex ( Figure 3H ). In accordance with previous studies, neocortical NIs developed only gradually and initially affected chiefly lower cortical layers [70, 71] . Although cortical involvement in MSA is reportedly rare [61, 70] , some studies have reported NL in the motor and supplementary motor cortex [72] and have suggested a relationship with striato-nigral involvement [73] . In the midbrain, GCIs and NRIs prominently involved the crura cerebri, which contains striatonigral 'comb' fibres [74] , the involvement of which might be linked to NL in the SN [12, 46, 75] . Similarly, the presence of severe GCIs and NRIs in the internal capsule ( Figure 3G ) could contribute to NL in the putamen and SN. In line with previous studies, we observed loss of hypothalamic neurons in cases of MSA-C (Table 1) [46, 76, 77] . The hypothalamus is of primary importance for thermoregulation, glucoregulation, osmoregulation, stress responses and immunomodulation [78] . Thus, its involvement could contribute to autonomic dysfunction in MSA-C [76] . Finally, MSA-C cases with a further increasing burden of pathology (phase 4, Table 1 ), were characterized by involvement of the entorhinal cortex, hippocampus ( Figure 3I-L) and the basolateral subnucleus of the amygdala.
Mechanisms of NL in MSA-C Remarkably, NL in MSA-C frequently affected groups of neurons that showed only mild a-syn aggregates (including neurons of the SN and the locus coeruleus, whereas the pathology is characterized by massive involvement of oligodendroglia [7, 46, 66, 75] . Furthermore, previous studies on cases of minimal change MSA with NL restricted to the substantia nigra and locus coeruleus, but more widespread GCI pathology, suggested that oligodendroglial pathology could lead to neuronal dysfunction and clinical symptoms before overt NL in MSA [79, 80] . We hypothesize that neuronal dysfunction and NL could be caused by GCI along myelinated axons at a considerable anatomical distance from the neuronal cell body. The mechanisms by which a-syn accumulation in GCIs could possibly lead to axonal dysfunction and neuronal death are still unknown, but both were seen in an earlier transgenic mouse model of MSA induced by a-syn overexpression [81] . There is increasing evidence that oligodendrocytes provide essential metabolic support to neurons by transferring glycolytic intermediates [82, 83] . Furthermore, oligodendrocytes are responsible for maintaining brain lipid homeostasis, and myelin instability was recently suggested to precede a-syn pathology in MSA [84, 85] . In addition, altered myelin protein composition including changes in the cellular interactions between MBP and p25a have been suggested to contribute to MSA pathology [20] .
Finally, it is unclear if the concept of 'prion-like' propagation attributed to other synucleinopathies can be extended to MSA [22, 23, 25, 27, [86] [87] [88] . Our findings point to a stereotypical spreading pattern of a-syn-containing lesions similar to what has been described for PD and DLB [28, 41] . A limitation of our study is the comparatively low number of cases with MSA-C available. It should therefore be regarded as a pilot-study that should entail a multi-centre follow-up effort to validate our findings and establish stages of a-syn pathology in MSA-C.
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